|
🐜
|
Treatment of older patients with mantle-cell lymphoma.
34 auth.
H. Kluin-Nelemans,
E. Hoster,
O. Hermine,
J. Walewski,
M. Trněný,
C. Geisler,
S. Stilgenbauer,
C. Thieblemont,
U. Vehling‐Kaiser,
J. Doorduijn,
B. Coiffier,
R. Forstpointner,
H. Tilly,
Lothar Kanz,
P. Feugier,
...
M. Szymczyk,
M. Hallek,
Stephan Kremers,
G. Lepeu,
L. Sanhes,
J. Zijlstra,
R. Bouabdallah,
P. Lugtenburg,
M. Macro,
M. Pfreundschuh,
V. Procházka,
F. Raimondo,
V. Ribrag,
M. Uppenkamp,
M. André,
W. Klapper,
W. Hiddemann,
M. Unterhalt,
M. Dreyling
|
8 |
2012 |
8
🐜
|
|
🐜
|
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
37 auth.
O. Hermine,
E. Hoster,
J. Walewski,
A. Bosly,
S. Stilgenbauer,
C. Thieblemont,
M. Szymczyk,
R. Bouabdallah,
M. Kneba,
M. Hallek,
G. Salles,
P. Feugier,
V. Ribrag,
J. Birkmann,
R. Forstpointner,
...
C. Haioun,
M. Hänel,
R. Casasnovas,
J. Finke,
N. Peter,
K. Bouabdallah,
C. Sebban,
T. Fischer,
U. Dührsen,
B. Metzner,
G. Maschmeyer,
L. Kanz,
C. Schmidt,
R. Delarue,
N. Brousse,
W. Klapper,
E. Macintyre,
M. Delfau-Larue,
C. Pott,
W. Hiddemann,
M. Unterhalt,
M. Dreyling
|
8 |
2016 |
8
🐜
|
|
🐜
|
Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
20 auth.
E. Hoster,
W. Klapper,
O. Hermine,
H. Kluin-Nelemans,
J. Walewski,
A. van Hoof,
M. Trněný,
C. Geisler,
F. Di Raimondo,
M. Szymczyk,
...
S. Stilgenbauer,
C. Thieblemont,
M. Hallek,
R. Forstpointner,
C. Pott,
V. Ribrag,
J. Doorduijn,
W. Hiddemann,
M. Dreyling,
M. Unterhalt
|
7 |
2014 |
7
🐜
|
|
🐜
|
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network.
22 auth.
C. Cheah,
C. Cheah,
A. George,
E. Giné,
A. Chiappella,
H. Kluin-Nelemans,
W. Jurczak,
K. Krawczyk,
H. Mociková,
P. Klener,
...
D. Šálek,
J. Walewski,
M. Szymczyk,
L. Smolej,
R. Auer,
D. Ritchie,
D. Ritchie,
L. Arcaini,
Michael E. Williams,
M. Dreyling,
J. Seymour,
J. Seymour
|
6 |
2013 |
6
🐜
|
|
🐜
|
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.
22 auth.
H. Kluin-Nelemans,
E. Hoster,
O. Hermine,
J. Walewski,
C. Geisler,
M. Trněný,
S. Stilgenbauer,
F. Kaiser,
J. Doorduijn,
G. Salles,
...
M. Szymczyk,
H. Tilly,
L. Kanz,
C. Schmidt,
P. Feugier,
C. Thieblemont,
J. Zijlstra,
V. Ribrag,
W. Klapper,
C. Pott,
M. Unterhalt,
M. Dreyling
|
6 |
2019 |
6
🐜
|
|
🐜
|
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network
21 auth.
M. Dreyling,
H. Kluin-Nelemans,
S. Beá,
E. Hartmann,
I. Salaverria,
G. Hutter,
P. Pérez-Galán,
G. Roué,
C. Pott,
S. Gouill,
...
S. Cortelazzo,
S. Rule,
G. Hess,
F. Zaja,
U. Vitolo,
M. Szymczyk,
J. Walewski,
V. Ribrag,
M. Unterhalt,
O. Hermine,
E. Hoster
|
5 |
2011 |
5
🐜
|
|
🐜
|
R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma
19 auth.
J. Kluin-Nelemans,
E. Hoster,
J. Walewski,
S. Stilgenbauer,
C. Geisler,
C. Gisselbrecht,
U. Vehling‐Kaiser,
J. Doorduijn,
M. Trněný,
B. Coiffier,
...
R. Forstpointner,
H. Tilly,
L. Kanz,
M. Szymczyk,
O. Hermine,
W. Klapper,
W. Hiddemann,
M. Unterhalt,
M. Dreyling
|
4 |
2011 |
4
🐜
|
|
🐜
|
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
26 auth.
O. Hermine,
Linmiao Jiang,
J. Walewski,
A. Bosly,
C. Thieblemont,
M. Szymczyk,
C. Pott,
G. Salles,
P. Feugier,
K. Hübel,
C. Haioun,
R. Casasnovas,
C. Schmidt,
K. Bouabdallah,
V. Ribrag,
...
L. Kanz,
J. Dürig,
B. Metzner,
D. Sibon,
M. Cheminant,
B. Burroni,
W. Klapper,
W. Hiddemann,
M. Unterhalt,
E. Hoster,
M. Dreyling
|
4 |
2022 |
4
🐜
|
|
🐜
|
Triangle: Autologous Transplantation after a Rituximab/Ibrutinib/ara-c Containing Induction in Generalized Mantle Cell Lymphoma - a Randomized European MCL Network Trial
16 auth.
M. Dreyling,
M. Ladetto,
J. Doorduijn,
E. Giné,
M. Jerkeman,
U. Mey,
M. Szymczyk,
M. Hutchings,
A. Kolstad,
G. Verhoef,
...
M. Trněný,
Maria Gomes da Silva,
C. Pott,
W. Klapper,
M. Unterhalt,
E. Hoster
|
4 |
2019 |
4
🐜
|
|
🐜
|
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials
22 auth.
E. Hoster,
C. Geisler,
J. Doorduijn,
B. Holt,
J. Walewski,
J. Bloehdorn,
Vincent Ribrag,
Gilles Salles,
Michael Hallek,
C. Pott,
...
M. Szymczyk,
A. Kolstad,
A. Laurell,
R. Raty,
M. Jerkeman,
M. V. Veer,
Johanna C Kluin-Nelemans,
Wolfram Klapper,
M. Unterhalt,
M. Dreyling,
Olivier Hermine,
Olivier Hermine
|
4 |
2016 |
4
🐜
|
